• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

• iTeos Therapeutics Appoints Matthew Call as COO (2019-08-13)
  iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, today announces the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development. Matthew joins iTeos ...
• Pharming Acquires Late Stage Orphan Drug from Novartis (2019-08-13)
  > CDZ173 is in a registration-enabling study for the treatment of APDS, an ultra-rare, debilitating disease with no approved treatment > APDS is treated by immunologists; the main physicians treating HAE and therefore already addressed by Pharming > Upfront p...
• Curetis Considers Strategic Options, Retains H.C. Wainwright (2019-08-12)
  > Investment bank supports Curetis in assessment of all strategic and tactical financing options > Publication of H1-2019 financials postponed to September 18, 2019 > Key financials show EUR 7.8 million cash as of June 30, 2019 and significantly reduced ca...
• Eurofins Genomics US Acquires Blue Heron Biotech (2019-08-06)
  Eurofins Genomics LLC (US) announces that it has completed the acquisition of Blue Heron Biotech, a company specializing in advanced gene synthesis. The acquisition provides valuable synergies for both companies due to the inherent connection between their main pro...
• Genetic Data Analysis: Platomics Gets € 7-digit Investment (2019-08-06)
  Medical diagnostics is undergoing a groundbreaking digital revolution and a visionary Austrian company is leading the way in personalized medicine. In concrete terms, Platomics is developing a digital platform for the analysis of genetic data. This enables the gene...
• Imcyse Appoints Thomas Taapken as Executive Chairman (2019-08-05)
  Company strengthens board ahead of trial results in type 1 diabetes patients and expansion of indications for its proprietary Imotope™ technology Imcyse, a clinical-stage company developing active and specific immunotherapeutics for the treatment and preven...
• AgroSavfe’s €35m Series C Led by Ackermans & van Haaren (2019-07-30)
  > AgroSavfe is a Belgium-based Company developing a new generation of safe and effective biocontrols > All existing, long-term investors participated in the capital round > Ackermans & van Haaren invested €10 million and joins the Board of the company ...
• Zambon Acquires Breath Therapeutics for up to €500m (2019-07-25)
  > Zambon, a privately held long-established Italian multinational company, extends its presence in severe respiratory diseases through the acquisition of Breath Therapeutics, a biopharmaceutical company developing an innovative inhalation therapy for Bronchiolitis ...
• Medicxi Closes New €400m Fund (Medicxi III) (2019-07-19)
  > €400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b > Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitiou...
• AM-Pharma Raises €116m Round Led by LSP & Andera Partners (2019-07-16)
  Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare Proceeds to be used for the 1,400-patient international piv...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.